Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)
China · Delayed Price · Currency is CNY 13.40
-0.43 (-3.11%)
Nov 6, 2026, 3:00 PM CST
SHA:600267 Market Cap
SHA:600267 has a market cap or net worth of 15.52 billion as of November 6, 2026. It is the 5,954th most valuable company in the world and the 1,033rd biggest in China. Its market cap has increased by 21.65% in one year.
Market Cap
15.52B
Enterprise Value
16.16B
Revenue
9.15B
Global Rank
Country Rank
#1,033 China
PE Ratio
12.89
ChartMarket Cap Chart
Since August 15, 2006, SHA:600267's market cap has increased from 2.44B to 15.52B, an increase of 537.45%. That is a compound annual growth rate of 9.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 15.52B | 34.94% |
| Dec 31, 2025 | 11.50B | 18.59% |
| Dec 31, 2024 | 9.70B | -12.87% |
| Dec 29, 2023 | 11.13B | -13.94% |
| Dec 30, 2022 | 12.94B | -22.69% |
| Dec 31, 2021 | 16.73B | 4.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kangmei Pharmaceutical | 18.95B |
| Walvax Biotechnology | 18.70B |
| China Resources Double-Crane Pharmaceutical | 16.63B |
| Tonghua Dongbao Pharmaceutical | 15.71B |
| Shandong Buchang Pharmaceuticals | 15.69B |
| China Resources Jiangzhong Pharmaceutical Co.,Ltd | 14.61B |
| Harbin Pharmaceutical Group | 14.61B |
| Shenzhen Kangtai Biological Products | 14.41B |